Yazawa N - Search Results

1

Anti-U1RNP antibodies in patients with localized scieroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: yazawa n. Arch Dermatol Res. 2001 Sep;293(9):455-9. doi: 10.1007/s004030100254. Arch Dermatol Res. 2001. PMID: 11758788

2

Serum matrix metalloproteinase-3 in systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: yazawa n. Arch Dermatol Res. 2004 Jun;296(1):25-9. doi: 10.1007/s00403-004-0468-1. Epub 2004 Apr 17. Arch Dermatol Res. 2004. PMID: 15095096

3

Serum levels of manganese superoxide dismutase in patients with localized scleroderma.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: yazawa n. Exp Dermatol. 2004 Jun;13(6):357-60. doi: 10.1111/j.0906-6705.2004.00160.x. Exp Dermatol. 2004. PMID: 15186321

4

Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.

Mimra Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K. Mimra Y, et al. Among authors: yazawa n. Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x. Int J Dermatol. 2005. PMID: 16207181

5

Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases.

Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, Sato S, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: yazawa n. Br J Dermatol. 1997 Dec;137(6):916-20. Br J Dermatol. 1997. PMID: 9470907

6

Increased serum concentration of hyaluronate in dermatomyositis patients.

Kubo M, Kikuchi K, Yazawa N, Fujimoto M, Tamaki T, Tamaki K. Kubo M, et al. Among authors: yazawa n. Arch Dermatol Res. 1998 Oct;290(10):579-81. doi: 10.1007/s004030050355. Arch Dermatol Res. 1998. PMID: 9836510 No abstract available.

7

Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yazawa N, Sato S, Kikuchi K, Tamaki K. Kubo M, et al. Among authors: yazawa n. J Invest Dermatol. 1999 May;112(5):711-5. doi: 10.1046/j.1523-1747.1999.00580.x. J Invest Dermatol. 1999. PMID: 10233761 Free article.

8

Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.

Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Sato S, Kikuchi K, Tamaki K. Ihn H, et al. Among authors: yazawa n. Clin Exp Immunol. 1999 Aug;117(2):383-7. doi: 10.1046/j.1365-2249.1999.00961.x. Clin Exp Immunol. 1999. PMID: 10444274 Free PMC article.

9

Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: yazawa n. J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):64-9. doi: 10.1016/s0190-9622(00)90010-0. J Am Acad Dermatol. 2000. PMID: 10607321

10

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: yazawa n. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters